Family Intervention for Mental Illness and Substance Abuse

This study has been completed.
Sponsor:
Collaborator:
Information provided by (Responsible Party):
Dartmouth-Hitchcock Medical Center
ClinicalTrials.gov Identifier:
NCT00043693
First received: August 12, 2002
Last updated: August 7, 2012
Last verified: August 2012

August 12, 2002
August 7, 2012
April 2002
December 2008   (final data collection date for primary outcome measure)
  • Alcohol use scale-revised [ Time Frame: Measured at baseline, during treatment, and post-treatment ] [ Designated as safety issue: No ]
  • Drug use scale-revised [ Time Frame: Measured at baseline, during treatment, and post-treatment ] [ Designated as safety issue: No ]
  • Substance abuse treatment scale [ Time Frame: Measured at baseline, during treatment, and post-treatment ] [ Designated as safety issue: No ]
  • Timeline followback calandar [ Time Frame: Measured at baseline, during treatment, and post-treatment ] [ Designated as safety issue: No ]
Not Provided
Complete list of historical versions of study NCT00043693 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Family Intervention for Mental Illness and Substance Abuse
Family Intervention for SMI and Substance Use Disorder

This study will evaluate a family intervention program for individuals with bipolar disorder, schizophrenia, or schizoaffective disorder and co-occurring substance use disorders.

Substance use disorder (SUD) in persons with severe mental illness may worsen the course of psychiatric illness. The loss of family support for individuals with mental illness is a major contributing factor to housing instability, homelessness, and other problems. Despite progress toward integrating mental health and substance abuse services, interventions that improve the course of mental illness while helping the families of the mentally ill are not currently available. Enhancing skills for coping with mental illness may be an effective strategy for treating SUD, decreasing caregiver burden, and improving the long-term outcomes for people with mental illness.

Patients and their families are randomly assigned to either the Family Intervention for Dual Diagnosis (FIDD) program or family psychoeducation. The FIDD program lasts for up to 3 years and includes both single and multiple-family group formats. The family psychoeducation program consists of 6 weekly sessions. Routine assessments are conducted on all patients, and relatives are evaluated on a wide range of outcomes, including substance abuse, hospitalizations, psychiatric symptoms, legal problems, aggression, housing and homelessness, family burden, social support, and quality of life. To determine the effectiveness of the FIDD program, knowledge of mental illness and problem-solving skills are assessed in the families following treatment.

Interventional
Not Provided
Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Treatment
  • Schizophrenia
  • Bipolar Disorder
  • Substance-related Disorders
  • Behavioral: Family Intervention for Dual Diagnosis
    The family intervention for dual diagnosis program lasts for up to 3 years and includes both single and multiple-family group formats.
  • Behavioral: Family psychoeducation program
    The family psychoeducation program consists of 6 weekly sessions.
  • Experimental: 1
    Participants will undergo the Family Intervention for Dual Diagnosis (FIDD) program.
    Intervention: Behavioral: Family Intervention for Dual Diagnosis
  • Active Comparator: 2
    Participants will be placed in a family psychoeducation program.
    Intervention: Behavioral: Family psychoeducation program
Mueser KT, Fox L. A family intervention program for dual disorders. Community Ment Health J. 2002 Jun;38(3):253-70.

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
108
December 2008
December 2008   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • Have schizophrenia, schizoaffective disorder, or bipolar disorder
  • Have a current substance use disorder (within the past 6 months)
  • Are willing to have at least 4 hours of contact per week with family members or significant others
  • Plan to remain in the community
  • Have family members or significant others who consent to participate in the study and plan to remain in the community
Both
18 Years to 65 Years
No
Contact information is only displayed when the study is recruiting subjects
United States
 
NCT00043693
R01 MH62629, R01MH062629, DSIR SE-CE
Not Provided
Dartmouth-Hitchcock Medical Center
Dartmouth-Hitchcock Medical Center
National Institute of Mental Health (NIMH)
Principal Investigator: Kim T. Mueser, PhD Dartmouth-Hitchcock Medical Center
Principal Investigator: Shirley Glynn, PhD University of California, Los Angeles
Dartmouth-Hitchcock Medical Center
August 2012

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP